NEKTAR THERAPEUTICS — Director's Dealing 2012

Sep 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2012-09-14

Reporting Person: WINGER DENNIS L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-14	Common Stock	P	5000	$9.1815	Acquired	5000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-14	Stock Option	$9.24	A	40000	Acquired	2020-09-13	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3750	Direct

Footnotes

F1: This stock option vests in equal monthly installments over a 1 year period beginning on September 30, 2012 based on the Reporting Person's continuous service to the Issuer.